Holdings
Octagon Capital Advisors LP
As of Jun 30, 2026, Octagon Capital Advisors LP reported 24 positions worth US$1.06B. Largest: Dianthus Therapeutics, Inc., Definium Therapeutics, Inc. and Abivax Sa. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Dianthus Therapeutics, Inc. | 1.84M | US$180M | −105K | Jun 30, 2026 |
| Definium Therapeutics, Inc. | 2.95M | US$139M | +510K | Jun 30, 2026 |
| Abivax Sa | 993K | US$132M | +316K | Jun 30, 2026 |
| Cogent Biosciences, Inc. | 2.35M | US$90.9M | no change | Jun 30, 2026 |
| Alumis Inc. | 2.83M | US$79.7M | no change | Jun 30, 2026 |
| Arrivent Biopharma, Inc. | 1.97M | US$68.5M | no change | Jun 30, 2026 |
| Taysha Gene Therapies, Inc. | 9.69M | US$66M | +833K | Jun 30, 2026 |
| Bioage Labs, Inc. | 1.75M | US$42.8M | no change | Jun 30, 2026 |
| Mirum Pharmaceuticals, Inc. | 339K | US$39.7M | no change | Jun 30, 2026 |
| Kymera Therapeutics, Inc. | 310K | US$35.5M | −115K | Jun 30, 2026 |